Post‑merger Remedies and Compliance in Vietnam 2026: What Buyers & Sellers Must Do After Clearance

Merger remedies vietnam has become one of the most pressing operational concerns for dealmakers as the country enters a tighter regulatory cycle in 2026, with the Competition Law framework and its implementing decrees combining to raise the stakes for post‑clearance conduct. Where parties once treated competition clearance as the finish line, the reality in Vietnam today is that clearance can be the beginning of a multi‑year compliance obligation involving undertakings, reporting duties and active supervision by the authorities. Enforcement is maturing, administrative fines can be significant, and reputational exposure for non‑compliance is real.

This practical guide explains what buyers, sellers and private equity sponsors should document, negotiate, implement and monitor after a conditional clearance, and how to build those obligations into the sale and purchase agreement (SPA) so that commercial risk is allocated correctly.

Introduction, why post‑clearance compliance matters in Vietnam 2026

For years, competition analysis in Vietnamese M&A focused almost entirely on notification thresholds and the mechanics of filing. That emphasis made sense when the regime was young and enforcement was modest. In 2026 the calculus has shifted. Vietnam’s Competition Law (Law No. 23/2018/QH14) and its implementing instruments give the Ministry of Industry and Trade (MOIT) and the Vietnam Competition Commission (VCC) broader supervisory tools, clearer reporting expectations and a more assertive sanctioning posture. The practical effect is that a conditional clearance, one granted subject to behavioural or structural remedies, can carry a tail of obligations that run for an extended period and expose both buyer and seller to audits, corrective orders and penalties.

Understanding merger remedies vietnam is therefore no longer a niche concern for antitrust specialists; it is a core deal‑risk issue that should be priced, allocated and operationalised. The sections below move from the legal basis for remedies, through timing and reporting, to the drafting of SPA clauses, monitoring programmes and the consequences of breach. Where a statement reflects the legal framework it is tied to an authoritative source; where it reflects practical interpretation it is flagged as commentary.

1. How merger remedies and undertakings are imposed in Vietnam (legal basis & types)

The authority to impose conditions on a concentration (economic concentration) derives from Vietnam’s Competition Law and its implementing instruments, as published through the Vietnam Law & Legal Documents Portal and the Government Portal. In broad terms, where a notified concentration raises a risk of significantly restricting competition, the competition authority may permit the transaction subject to conditions designed to preserve competitive conditions. These conditions are recorded in the clearance decision and become binding obligations on the notifying parties.

Remedies fall into two broad families, behavioural and structural, and clearance decisions can combine elements of both. Alongside formal conditions, parties may offer undertakings (commitments) to address the authority’s concerns, and the distinction between an imposed condition and a voluntarily offered undertaking matters for how it is documented and enforced.

Behavioural vs structural merger remedies

Behavioural remedies regulate the merged entity’s conduct going forward. Typical examples include obligations to continue supplying certain customers on non‑discriminatory terms, commitments not to bundle products, firewalls to prevent the misuse of competitively sensitive information, and pricing or access undertakings. They are generally cheaper to accept but harder to monitor, because compliance depends on ongoing behaviour rather than a single event.

Structural remedies change the shape of the market. The clearest example is divestiture, the sale of a business unit, brand, production facility or portfolio of assets to an approved purchaser. Related structural measures include licensing of intellectual property, the grant of long‑term access to infrastructure, and “hold‑separate” obligations that ring‑fence a business pending disposal. Structural remedies are often preferred by competition authorities internationally, as OECD guidance notes, because they can resolve the concern definitively and require less long‑term supervision once implemented.

Undertakings, what they look like in practice

Commentary: In practice, undertakings in Vietnam tend to be hybrid. A buyer may offer a divestiture package combined with transitional behavioural commitments, for instance, an agreement to supply the divested business during a carve‑out period and to refrain from soliciting its key customers. The drafting of these undertakings is critical: they should be precise enough to be auditable, include a clear implementation timetable, and specify who within the merged group owns compliance. Vague undertakings invite disputes with the authority and create uncertainty between buyer and seller about who bears the cost of performance. Treating undertakings as live operational commitments, not boilerplate, is the single most important mindset shift for parties entering the post‑clearance phase.

2. Typical timing, duration and reporting obligations after clearance

Once a conditional clearance is issued, the clock starts on a sequence of deadlines. The clearance decision itself is the governing document: it sets the implementation timetable, the first reporting date, the ongoing reporting cadence and the circumstances in which an ad‑hoc report is required. Parties should treat the decision as a compliance instrument and extract every deadline into a monitored calendar on day one.

Durations vary with the type of remedy. Drawing on international practice reflected in OECD and UNCTAD materials, monitoring periods commonly span several years. Behavioural remedies, such as supply or non‑discrimination commitments, tend to sit at the longer end, because they regulate continuing conduct. A structural divestiture, by contrast, may carry a short, intensive implementation window followed by a residual obligation to maintain separation until completion. The precise duration is at the authority’s discretion and must be read from the clearance decision rather than assumed.

Initial reporting & first 90 days checklist

The first ninety days after clearance are where many compliance failures originate, usually through oversight rather than bad faith. A disciplined opening programme should include:

• Extract and calendar every deadline from the clearance decision, including the first report date and periodic cadence.
• Appoint a named remedy owner with authority and budget, and notify the authority of the designated contact where required.
• Freeze prohibited integration steps where hold‑separate or firewall obligations apply, and document the controls in place.
• Prepare the first compliance report template aligned to the specific undertakings, so reporting is consistent period to period.
• Brief operational teams whose day‑to‑day conduct touches the remedy, sales, procurement, IT and legal.

3. Implementation: what buyers and sellers must put in place immediately after clearance

Clearance conditions are only as good as the operational machinery built to deliver them. Effective merger remedies vietnam compliance depends on translating the clearance decision into governance structures, internal controls and documented processes that survive personnel changes and integration pressure. The parties should assume that the authority may review compliance, and build a programme capable of producing evidence on demand.

The implementation effort splits into two linked workstreams: a governance playbook that assigns clear accountability, and a data‑and‑information control regime that prevents the operational leakage most likely to breach behavioural remedies.

Internal compliance playbook (roles & responsibilities)

A robust playbook designates a single remedy owner, typically a senior in‑house lawyer or compliance officer, supported by a cross‑functional committee. The owner is responsible for reporting, liaison with the authority, and escalation of potential breaches. Responsibilities should be documented so there is no ambiguity about who signs off on reports, who approves conduct that touches a behavioural commitment, and who authorises remedial action.

The playbook should also embed training. Employees in affected business lines need to understand, in plain terms, what they can and cannot do, for example, that they may not share pricing data across a firewall, or that they must continue to supply a protected customer on agreed terms. Training should be refreshed periodically and recorded, because evidence of a functioning compliance culture can materially affect how an authority treats an inadvertent lapse. Commentary: authorities commonly respond differently to a party that self‑identifies and corrects a slip within a documented programme than to one that appears to have ignored its obligations.

Data and information flows, common pitfalls

Information leakage is a frequent source of behavioural‑remedy breaches. The classic failure modes are predictable: shared IT systems that give the acquirer access to a hold‑separate business’s commercially sensitive data; integration teams that circulate pricing or customer information across a firewall; and management overlaps where the same executives sit on both sides of a required separation.

The controls to prevent this are equally concrete. Parties should segregate IT access and audit logs, impose contractual and physical firewalls around sensitive information, restrict the flow of competitively significant data through a defined “clean team”, and keep clear records of what information crossed which boundary and why. Where a transitional services arrangement is necessary, its scope should be tightly drawn and consistent with the clearance conditions. Getting information‑flow discipline right from day zero is one of the most cost‑effective investments in post‑clearance compliance a buyer can make.

See the Merger Remedies Checklist (Vietnam 2026) below to operationalise these steps across your deal team.

4. Drafting and negotiating SPA clauses for merger remedies vietnam

The SPA is where the commercial risk of remedies is allocated between buyer and seller. Because remedy performance frequently depends on both parties, the seller may need to provide transitional support, the buyer must implement and report, the agreement should spell out obligations, cost allocation and consequences with precision. The following drafting themes recur in well‑structured deals.

• Remedy implementation covenant. A positive obligation on the relevant party to implement the clearance conditions in accordance with the decision’s timetable, at defined cost responsibility.
• Reporting and cooperation. Mutual obligations to provide information, co‑sign reports to the authority and support reviews, with confidentiality protections.
• Escrow or holdback tied to performance. A portion of consideration retained pending completion of a divestiture or satisfaction of key undertakings.
• Termination and step‑in rights. Mechanisms allowing one party to act, or to walk away from part of the deal, if the other fails to perform a required remedy.
• Indemnity versus specific performance. A considered choice between damages‑based protection and the right to compel actual implementation.
• Warranties and disclosure. Representations about compliance status and the disclosure of any communications with the authority.

Sample SPA remedial clause (buyer‑favour / seller‑favour)

SAMPLE CLAUSE, for illustrative purposes only. Does not constitute legal advice.

Buyer‑favour (implementation and indemnity): “The Seller shall, and shall procure that the Target Group shall, implement and comply in full with each Clearance Condition in accordance with the timetable set out in the Clearance Decision, and shall indemnify the Buyer on demand against any fine, penalty, corrective cost or loss arising from any failure to do so, such indemnity to be uncapped in respect of amounts imposed by the Competition Authority. Pending completion of the Divestiture, the Seller shall maintain the Hold‑Separate Business as a distinct and viable business and shall not permit the transfer of competitively sensitive information in breach of any firewall required by the Clearance Decision.”

Seller‑favour (cooperation and shared responsibility): “The Buyer shall assume primary responsibility for implementing each Clearance Condition from Completion and shall bear all costs of such implementation and of ongoing reporting to the Competition Authority. The Seller’s obligations shall be limited to providing reasonable cooperation and transitional support for a period not exceeding [X] months, and the Seller shall have no liability for any breach of a Clearance Condition to the extent arising from the Buyer’s acts or omissions after Completion.”

Commentary: the negotiation almost always turns on who controls the business that must perform the remedy after completion. Where the buyer takes control, a seller will resist open‑ended liability for conduct it cannot direct; where the seller retains a divestiture obligation, the buyer will want security that it is performed. Escrow is the usual bridge between these positions.

Escrow and price adjustment mechanics tied to remedy performance

Linking consideration to remedy performance aligns incentives. A common structure retains a defined escrow amount released on independent confirmation that a divestiture has completed or that a behavioural commitment has been satisfied for a stated period. Alternatively, a price adjustment can reduce consideration if a remedy proves more costly or protracted than assumed. The drafting should specify the release trigger objectively, ideally by reference to the authority’s confirmation or a monitor’s certification, to avoid disputes about whether the condition has been met. Escrow timelines should be synchronised with the clearance decision’s monitoring period so that security is not released before the compliance risk has run off.

5. Monitoring programmes: setting KPIs, audits and independent monitors

A monitoring programme converts abstract undertakings into measurable, auditable performance. The programme should define key performance indicators that map directly to each remedy, schedule periodic internal audits, retain evidence, and establish reporting lines to the remedy owner and, where required, the authority. For behavioural remedies, KPIs might include the proportion of protected customers supplied on compliant terms, the number of firewall exceptions logged, or the timeliness of required disclosures. For structural remedies, the key metric is progress against the divestiture timetable and the ongoing viability of the hold‑separate business.

In more complex cases, the authority may require an independent monitor to oversee compliance, a practice well established in international merger control and reflected in OECD and UNCTAD guidance on remedy design. The monitor can provide the authority with independent assurance and reduce the supervisory burden the agency would otherwise carry.

Selecting an independent monitor, scope and reporting lines

Where a monitor is used, the parties should expect to propose candidates for the authority’s approval, agree detailed terms of reference, and fund the role. The monitor’s scope typically covers verifying implementation of the remedy, reviewing reports before submission, conducting on‑site audits, and flagging non‑compliance. Reporting lines run to the authority, with the parties receiving copies, and the monitor is usually bound by strict confidentiality to protect competitively sensitive information gathered during audits. The monitor may hold limited recommendation powers, for example, the ability to require the parties to remedy a shortfall within a set period. Clear terms of reference at the outset prevent later friction over the monitor’s remit and cost.

6. Enforcement, sanctions and consequences of remedy breaches

Breaching a remedy or undertaking after clearance exposes the parties to a graduated set of consequences. Under the Competition Law framework, as published through the Vietnam Law & Legal Documents Portal and the Government Portal, the authority may impose administrative sanctions, issue corrective orders requiring the party to bring itself back into compliance, and in serious cases take further action affecting the transaction. The applicable sanctions and their levels are set by the governing law and implementing decrees in force at the time. Beyond the direct legal sanction, the reputational cost of a public enforcement action, and its impact on future regulatory relationships, can outweigh the fine itself.

These public consequences sit alongside the private remedies negotiated in the SPA. A breach that triggers an authority sanction will typically also trigger the contractual indemnity, escrow release provisions or step‑in rights agreed between the parties, so a single compliance failure can crystallise liability on two fronts simultaneously. This interaction is precisely why the SPA drafting discussed above matters so much.

Responding to an authority inquiry, 7 quick steps

1. Acknowledge and log the inquiry immediately, noting any deadline stated by the authority.
2. Notify the remedy owner and legal counsel without delay and convene the compliance committee.
3. Preserve documents relevant to the undertaking in question, including internal communications and audit records.
4. Assess the factual position against the clearance decision before responding substantively.
5. Prepare a measured, evidenced response that demonstrates the compliance programme in operation.
6. Consider voluntary remediation where a gap exists, and document the corrective steps taken.
7. Check SPA notification obligations and give any required notice to the counterparty to preserve indemnity rights.

7. Comparison: gun‑jumping vs post‑clearance obligations

Parties sometimes conflate two distinct compliance risks, gun‑jumping and post‑clearance obligations, but they arise at different stages and demand different responses. Gun‑jumping concerns premature implementation of a concentration before clearance and is prohibited conduct; post‑clearance obligations concern the implementation and monitoring of remedies after clearance is granted. The practical compliance focus differs accordingly, and the SPA treatment differs too.

The two risks overlap at the boundary: a hold‑separate obligation, for example, can function both as a pre‑completion discipline and as a post‑clearance condition. The safest approach is to maintain integration discipline continuously, before and after clearance, until every relevant obligation has formally fallen away.

8. Practical checklist & implementation timeline

The following consolidated timeline shows how merger remedies vietnam obligations typically unfold from completion through the monitoring period. Use it as the backbone of your compliance programme and adapt it to the specific clearance decision.

• Day 0 (clearance / completion): extract all deadlines, appoint the remedy owner, notify the authority of the contact where required, and activate hold‑separate and firewall controls.
• First 90 days: prepare reporting templates, train affected teams, document data‑segregation controls and submit any initial report required.
• Months 3–12: run the first periodic reports, conduct internal audits against KPIs, progress any divestiture, and liaise with an independent monitor if appointed.
• Subsequent years: maintain periodic reporting at the cadence set by the decision, refresh training, respond to ad‑hoc requests, and track escrow release triggers tied to remedy performance.
• End of monitoring period: confirm with the authority (and the monitor) that obligations are discharged before relaxing controls or releasing retained consideration.

Build this timeline into a shared compliance calendar with automated reminders, and keep an evidence file for every reporting cycle so the programme can withstand a review at any point.

Conclusion & next steps

Managing merger remedies vietnam in 2026 demands a disciplined, documented programme that begins the moment clearance is granted and runs through the full monitoring period. The essential actions are consistent across deals: extract every obligation from the clearance decision, appoint an accountable remedy owner, build governance and data‑segregation controls, draft SPA clauses that allocate cost and liability clearly, operate a measurable monitoring programme, and respond swiftly and evidentially to any authority inquiry. As enforcement of Vietnam’s competition regime continues to mature, the cost of getting this wrong has risen, but so has the value of getting it right. Parties that treat post‑clearance compliance as an operational discipline, not an afterthought, protect both the deal and their standing with the regulator.

For transaction‑specific guidance, speak with an experienced Vietnam M&A adviser before clearance conditions crystallise into binding obligations you are not prepared to meet.

Explore the M&A lawyers: Vietnam, regulatory overview or review the author profile for Ngan Nguyen.

Sources

1. Ministry of Industry and Trade (MOIT)
2. Vietnam Law & Legal Documents Portal (VBPL), Ministry of Justice
3. Vietnam Government Portal (Chinhphu)
4. National Assembly of Vietnam (Quoc Hoi)
5. OECD, Competition
6. UNCTAD, Competition & Consumer Protection